This Article  • Full text  • PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citing articles on HighWire  • Citing articles on ISI (14)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Topic Collections  • Oncology  • Head & Neck Cancer  • Neoplasms of Head & Neck  • Alert me on articles by topic

Is Salvage Possible?

Lyon L. Gleich, MD; John Ryzenman, MD; Jack L. Gluckman, MD; Keith M. Wilson, MD; William L. Barrett, MD; Kevin P. Redmond, MD

Arch Otolaryngol Head Neck Surg. 2004;130:35-38.

Background  Salvage surgery is often the only curative option for recurrent cancer. In patients whose initial tumor is stage T3 or T4, the primary therapy often makes salvage even more difficult. We therefore analyzed the outcome in patients who were originally treated for T3 or T4 squamous cell carcinoma of the oral cavity, larynx, oropharynx, or hypopharynx and who then had a recurrence and chose to undergo further therapy for cure.

Patients and Methods  From 1980 to 2000, a total of 940 patients were treated for stage T3 or T4 cancer. Forty-eight patients underwent salvage therapy for recurrence: 24 for primary site recurrence, 20 for regional recurrence, and 4 for locoregional recurrence.

Results  The mean time to recurrence was 14.0 months, and the mean survival time was 26.2 months. Among the 28 patients treated for primary site recurrence, the mean time to rerecurrence was 12.6 months, and the mean survival time was 27.3 months. Only 5 of the 28 patients had prolonged survival. The stage of the recurrent disease did not influence outcome. Among the 20 patients treated for neck recurrence, the mean time to recurrence was 14.0 months, and the mean survival time was 25.0 months. Six of the 20 patients had prolonged survival, but none had a recurrence in a previously dissected and irradiated neck.

Conclusions  These results show the limited potential for survival in patients who have a recurrence after treatment for advanced primary site head and neck cancer. Patients who have not undergone all modalities of therapy have the potential for salvage, but even then the chances are limited. Given the morbidity of salvage therapy, and the limited chance for cure, physicians must cautiously counsel patients who are contemplating treatment of recurrent cancer after therapy for advanced disease.

From the Departments of Otolaryngology–Head and Neck Surgery (Drs Gleich, Ryzenman, Gluckman, and Wilson) and Radiation Oncology (Drs Barrett and Redmond), University of Cincinnati, Cincinnati, Ohio. The authors have no relevant financial interest in this article.

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Salvage Surgery for Recurrent Carcinoma of the Hypopharynx and Reconstruction Using Jejunal Free Tissue Transfer and Pectoralis Major Muscle Pedicled Flap
Dubsky et al.
Arch Otolaryngol Head Neck Surg 2007;133:551-555.
ABSTRACT | FULL TEXT